Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | MRKRMarker Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $3.55M |
| Revenue, yoy | −46.2% |
| Net income | $12.16M |
| Net income, yoy | −13.3% |
| Net margin | -343.0% |
| Free cash flow | $18.66M |
| FCF margin | — |
| EPS, diluted | $0.79 |
Add another company.